Valuation: Shanghai Pharmaceuticals Holding Co., Ltd

Market Cap 5.49TCr 809.78Cr 710.25Cr 657.83Cr 605.27Cr 1.14TCr 78TCr 1.17TCr 7.84TCr 3.08TCr 38TCr 3.04TCr 2.97TCr 1,31400Cr P/E 2026 *
11.3x
P/E 2027 * 10.2x
Enterprise Value 5.96TCr 878.66Cr 770.67Cr 713.79Cr 656.76Cr 1.24TCr 84TCr 1.27TCr 8.51TCr 3.34TCr 41TCr 3.3TCr 3.23TCr 1,42600Cr EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.21x
Free-Float
41.21%
Yield 2026 *
2.65%
Yield 2027 * 2.92%
Manager TitleAgeSince
President 56 29/06/2023
Director of Finance/CFO 53 05/06/2013
Chief Tech/Sci/R&D Officer 63 01/10/2024
Director TitleAgeSince
Director/Board Member 53 28/06/2016
Director/Board Member 62 25/06/2026
Director/Board Member 56 27/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-3.18%+4.04% - - 809.78Cr
-0.07%+0.50%+13.39%+98.14% 9.51TCr
-0.99%-3.92%+42.44%+147.27% 5.47TCr
0.00%+3.55%+3.91%+279.22% 2.33TCr
-0.75%-4.20%-27.34%-35.59% 754.21Cr
+0.95%-0.06%-11.13%-27.46% 670.85Cr
-0.84%-5.39%+19.72%+30.60% 615.55Cr
-0.29%+0.87%-1.74%+22.84% 536.36Cr
+1.00%+0.20%-5.24%-6.75% 372.12Cr
+0.51%-1.71%+11.44%+15.73% 335.57Cr
Average -0.36%+0.33%+5.05%+58.22% 2.29TCr
Weighted average by Cap. -0.37%+1.60%+17.17%+115.47%

Financials

2026 *2027 *
Net sales 30TCr 4.38TCr 3.85TCr 3.56TCr 3.28TCr 6.2TCr 4,19600Cr 6.32TCr 42TCr 17TCr 2,06100Cr 16TCr 16TCr 7,11700Cr 32TCr 4.65TCr 4.08TCr 3.78TCr 3.47TCr 6.57TCr 4,45000Cr 6.7TCr 45TCr 18TCr 2,18500Cr 17TCr 17TCr 7,54600Cr
Net income 534.52Cr 79Cr 69Cr 64Cr 59Cr 111.45Cr 7.55TCr 113.62Cr 763.26Cr 299.36Cr 3.71TCr 296.02Cr 289.55Cr 13TCr 560.24Cr 83Cr 72Cr 67Cr 62Cr 116.81Cr 7.91TCr 119.09Cr 799.98Cr 313.76Cr 3.88TCr 310.26Cr 303.48Cr 13TCr
Net Debt 467.05Cr 69Cr 60Cr 56Cr 51Cr 97Cr 6.59TCr 99Cr 666.92Cr 261.57Cr 3.24TCr 258.65Cr 253Cr 11TCr 1.27TCr 186.81Cr 163.85Cr 151.75Cr 139.63Cr 264.11Cr 18TCr 269.25Cr 1.81TCr 709.38Cr 8.78TCr 701.48Cr 686.14Cr 30TCr
Logo Shanghai Pharmaceuticals Holding Co., Ltd
Shanghai Pharmaceuticals Holding Co Ltd is a China-based company mainly engaged in pharmaceutical distribution business. The Company mainly operates four business segments. The Industrial segment is mainly engaged in the research and development, production, and sales of drugs and health products. The Distribution segment is mainly engaged in providing distribution, warehousing, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and distributors. The Retail segment is mainly engaged in operating and franchising the retail pharmacy network. The Others segment mainly engage in other businesses. The Company mainly operates its businesses in the domestic market.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-